Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
ID07429214

Workflow Study of the VARIPULSE Catheter with the TRUPULSE Generator for Treatment of Paroxysmal or Persistent Atrial Fibrillation Using the New VARIPULSE Pro Software

Led by Biosense Webster, Inc. · Updated on 2026-05-11

50

Participants Needed

10

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the use and workflow of the pulsed field (PF) ablation system, including the VARIPULSE catheter, TRUPULSE generator, and new VARIPULSE Pro software, in participants with paroxysmal atrial fibrillation (PAF) or persistent atrial fibrillation (PsAF). These heart rhythm disorders involve irregular heartbeats of varying durations, and the study aims to better understand the clinical use of this device setup for cardiac ablation. The study is interventional and sponsored by Biosense Webster, Inc. Participants will undergo cardiac ablation using the pulsed field ablation system with the VARIPULSE catheter and TRUPULSE generator combined with the VARIPULSE Pro software. This procedure targets pulmonary vein isolation (PVI) and may include cavotricuspid isthmus (CTI) dependent atrial flutter ablation. The study focuses on the ablation procedure workflow and device application during the treatment of symptomatic PAF or PsAF. Throughout the study, researchers will measure outcomes such as total procedure time, pulsed field application time, number of applications at different heart locations, pulmonary vein isolation time, fluoroscopy time, catheter dwell time, and acute effectiveness during the procedure. Safety outcomes include monitoring for serious and non-serious adverse device effects up to three months after the procedure. Participants will need to comply with all pre-, post-, and follow-up assessments, including testing and clinical evaluations, during the study period.

CONDITIONS

Brief Title

A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with symptomatic persistent atrial fibrillation (PsAF) or paroxysmal atrial fibrillation (PAF)
  • Selected to undergo ablation procedure for arrhythmia management by pulmonary vein isolation (PVI) only or PVI with cavotricuspid isthmus (CTI) dependent atrial flutter ablation
  • Failed at least one antiarrhythmic drug (class I to IV) due to recurrent symptoms or intolerance
  • Age between 18 and 75 years
  • Willing and able to provide informed consent
  • Able and willing to comply with all pre-, post-, and follow-up testing and study requirements
Not Eligible

You will not qualify if you...

  • Continuous atrial fibrillation lasting longer than 12 months (longstanding persistent AF)
  • Previous surgical or catheter ablation for atrial fibrillation
  • Cardiac surgery or percutaneous coronary intervention within 60 days before consent
  • Previous coronary artery bypass grafting with valvular surgery or other cardiac surgery
  • Carotid stenting or endarterectomy
  • Presence of left atrium thrombus
  • Severe left atrial dilation (diameter >50 mm by transthoracic echocardiography)
  • Severely reduced left ventricular ejection fraction (<40%)
  • Significant pulmonary vein anomalies or prior pulmonary vein stenosis
  • Pre-existing hemi diaphragmatic paralysis
  • History of blood clotting or bleeding disorders or contraindication to anticoagulation
  • Myocardial infarction within 60 days prior to consent
  • Documented thromboembolic event within 6 months prior to consent
  • Rheumatic heart disease
  • Uncontrolled heart failure (NYHA class III or IV)
  • Severe mitral regurgitation
  • Planned cardiac transplantation, surgery, or major surgery within 12 months
  • Unstable angina within 6 months prior to consent
  • Acute illness, infection, or sepsis
  • Atrial fibrillation due to reversible or non-cardiac causes
  • Cardiac structural abnormalities preventing catheter use
  • Conditions precluding vascular access or catheter manipulation
  • Significant pulmonary or respiratory disease causing chronic symptoms
  • Significant congenital anomalies or medical problems precluding enrollment
  • Pregnancy, lactation, or planning pregnancy during study
  • Current enrollment in another investigational trial
  • Contraindications for the study devices
  • Vulnerable populations needing special safeguards
  • Life expectancy less than 12 months
  • Contraindications for MRI or presence of iron-containing metal fragments
  • Unresolved neurological deficits

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Single procedure day

Participants undergo pulsed field ablation using the VARIPULSE Catheter and TRUPULSE Generator with VARIPULSE Pro software to treat atrial fibrillation.

1 procedure visit (in-person)

Post-operative Follow-up

Duration - Up to 3 months

Participants are monitored for safety and effectiveness following the ablation procedure.

Multiple follow-up visits over 3 months

Trial Site Locations

Total: 10 locations

1

AZORG campus Aalst Moorselbaan

Aalst, Belgium, 9300

Not Yet Recruiting

2

A.Z. Sint Jan

Bruges, Belgium, 8000

Not Yet Recruiting

3

Aarhus University Hospital

Aarhus N, Denmark, 8200

Not Yet Recruiting

4

Hospices Civils de Lyon HCL

Bron, France, 69500

Not Yet Recruiting

5

Institut Medico chirurgical Montsouris

Paris, France, 75014

Not Yet Recruiting

6

University Hospital of the Ruhr-University of Bochum

Bad Oeynhausen, Germany, 32545

Not Yet Recruiting

7

Azienda Ospedaliera Universitaria 'Policlinico Tor Vergata'

Roma, Italy, 00133

Not Yet Recruiting

8

IRCCS Policlinico San Donato

San Donato Milanese, Italy, 20097

Not Yet Recruiting

9

Vilnius University Hospital Santaros Clinics

Vilnius, Lithuania, 08406

Actively Recruiting

10

Erasmus MC

Rotterdam, Netherlands, 3015

Not Yet Recruiting

Loading map...

Research Team

N

Nathalie Macours

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

320-detector Computed Tomography to Assess Myocardial Extrac...

Atrial Fibrillation

Actively Recruiting

1 location

Assessment of Long-Term Safety and Effectiveness in Treatmen...

Atrial Fibrillation

Actively Recruiting

19 locations

Assessment of Safety and Effectiveness of BWI Pulsed Field A...

Atrial Fibrillation

Actively Recruiting

46 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here